RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15
Molecules and Cells · 2023
DOI: 10.14348/molcells.2023.2136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules and Cells, 2023. Verfasst von Hao Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Jinling Hospital, Jinling Clinical Medical College of Nanjing Medical University, Nanjing 211166, China. Hauptthemen laut MEDLINE: Arthritis, Experimental, Arthritis, Rheumatoid. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Jinling Hospital, Jinling Clinical Medical College of Nanjing Medical University, Nanjing 211166, China.
- These authors contributed equally to this work.
- Department of Orthopedics, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou 225300, China.
ORCID-Profile: Hao Ding, Xiaoliang Mei, Lintao Li, Peng Fang, Ting Guo, Jianning Zhao
Zitieren
APA
Ding, H., Mei, X., Li, L., Fang, P., Guo, T., & Zhao, J. (2023). RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15. Molecules and Cells. https://doi.org/10.14348/molcells.2023.2136
Vancouver
Ding H, Mei X, Li L, Fang P, Guo T, Zhao J. RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15. Molecules and Cells. 2023. doi:10.14348/molcells.2023.2136
BibTeX
@article{Ding2023,
author = {Ding, Hao and Mei, Xiaoliang and Li, Lintao and Fang, Peng and Guo, Ting and Zhao, Jianning},
title = {RUNX1 Ameliorates Rheumatoid Arthritis Progression through Epigenetic Inhibition of LRRC15},
journal = {Molecules and Cells},
year = {2023},
doi = {10.14348/molcells.2023.2136}
}
EUVIMED